Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Therapeutic options in anti-jo-1 antisynthetase syndrome with interstitial lung disease: comment on the article by Marie et al.

Cavagna L, Caporali R.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1548. doi: 10.1002/acr.22024. No abstract available.

2.

Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.

Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A, Cherin P, Mouthon L, Vittecoq O, Menard JF, Jouen F.

Arthritis Care Res (Hoboken). 2013 May;65(5):800-8. doi: 10.1002/acr.21895.

3.

Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.

Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE.

Clin Rheumatol. 2007 Jan;26(1):108-11. Epub 2005 Nov 23.

PMID:
16328094
4.

Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies.

Tomonaga M, Sakamoto N, Ishimatsu Y, Kakugawa T, Harada T, Nakashima S, Hara A, Hara S, Horai Y, Kawakami A, Mukae H, Kohno S.

Lung. 2015 Feb;193(1):79-83. doi: 10.1007/s00408-014-9665-7. Epub 2014 Nov 14. Erratum in: Lung. 2016 Oct;194(5):869.

PMID:
25394672
5.

Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.

Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP.

Arthritis Rheum. 2009 Jul;60(7):2183-92. doi: 10.1002/art.24631.

6.

Clinical implications of autoantibody screening in patients with autoimmune myositis.

Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A.

Autoimmunity. 2006 May;39(3):217-21.

PMID:
16769655
7.

Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.

Ascherman DP.

Curr Rheumatol Rep. 2015 Sep;17(9):56. doi: 10.1007/s11926-015-0532-1. Review.

PMID:
26210509
8.

[Antisynthetase syndrome].

Gran JT.

Tidsskr Nor Laegeforen. 2002 Sep 30;122(23):2270-2. Norwegian.

9.

Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis. Expanding the clinical spectrum of the antisynthetase syndrome.

Queiro-Silva R, Bañegil I, de Dios-Jiménez de Aberásturi JR, Belzunegui-Otano J, González-Beneitez C, Figueroa-Pedrosa M.

J Rheumatol. 2001 Jun;28(6):1401-4.

PMID:
11409138
10.

Antisynthetase syndrome: not just an inflammatory myopathy.

Chatterjee S, Prayson R, Farver C.

Cleve Clin J Med. 2013 Oct;80(10):655-66. doi: 10.3949/ccjm.80a.12171. Review.

PMID:
24085811
11.

Rituximab in life threatening antisynthetase syndrome.

Vandenbroucke E, Grutters JC, Altenburg J, Boersma WG, ter Borg EJ, van den Bosch JM.

Rheumatol Int. 2009 Oct;29(12):1499-502. doi: 10.1007/s00296-009-0859-x. Epub 2009 Feb 1.

PMID:
19184665
12.

[The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].

Häussermann A, Gillissen A, Seidel W.

Pneumologie. 2010 Aug;64(8):496-503. doi: 10.1055/s-0029-1244054. Epub 2010 Apr 12. German.

13.

A patient with antisynthetase syndrome associated with deforming arthritis and periarticular calcinosis sine myositis.

Oztürk MA, Unverdi S, Goker B, Haznedaroglu S, Tunç L.

Scand J Rheumatol. 2007 May-Jun;36(3):239-41. No abstract available.

PMID:
17657684
14.

Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.

Mielnik P, Wiesik-Szewczyk E, Olesinska M, Chwalinska-Sadowska H, Zabek J.

Autoimmunity. 2006 May;39(3):243-7.

PMID:
16769658
15.

Antisynthetase syndrome and malignancy: our experience.

Castañeda-Pomeda M, Prieto-González S, Grau JM.

J Clin Rheumatol. 2011 Dec;17(8):458. doi: 10.1097/RHU.0b013e31823b1878. No abstract available.

PMID:
22126809
16.

[The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease].

Jordan Greco AS, Métrailler JC, Dayer E.

Rev Med Suisse. 2007 Nov 21;3(134):2675-6, 2679-81. French.

PMID:
18159702
17.

Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.

Barbasso Helmers S, Englund P, Engström M, Ahlin E, Fathi M, Janciauskiene S, Heimbürger M, Rönnelid J, Lundberg IE.

Arthritis Rheum. 2009 Aug;60(8):2524-30. doi: 10.1002/art.24683. Erratum in: Arthritis Rheum. 2009 Sep;60(9):2746.

18.

[Two cases of interstitial pneumonia with anti-Jo-1 antibodies in the absence of myositis].

Kinebuchi S, Mizuno K, Moriyama H, Ooi H, Hasegawa T, Yoshizawa H, Suzuki E, Gejyo F.

Nihon Kokyuki Gakkai Zasshi. 2003 Oct;41(10):739-45. Japanese.

PMID:
14584396
19.

In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.

La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F.

Autoimmunity. 2006 May;39(3):249-53.

PMID:
16769659
20.

[Antisynthetase syndrome. Three cases and a review of the literature].

Imbert-Masseau A, Hamidou M, Agard C, Halloun A, Delangle MH, Audrain M, Grolleau JY, Mussini JM.

Ann Med Interne (Paris). 2003 Nov;154(7):483-8. Review. French.

PMID:
14732841

Supplemental Content

Support Center